☆ 4.2 Review

The place of screening in the management of abdominal aortic aneurysm

SCANDINAVIAN JOURNAL OF SURGERY (2008)

期刊

SCANDINAVIAN JOURNAL OF SURGERY

卷 97, 期 2, 页码 136-138

出版社

FINNISH SURGICAL SOC

DOI: 10.1177/145749690809700212

关键词

abdominal aortic aneurysm; screening; mortality; cost effectiveness; UK National AAA; screening programme

类别

Surgery

向作者/读者索取更多资源

Protocol

Reagent

摘要

The present method of management of Abdominal Aortic Aneurysms (AAA) is ineffective in preventing AAA rupture. 5000 people still die of AAA in the UK each year. Improvements in surgery can only reduce the mortality in the minority who reach hospital following chance detection, and then only by a few percent. Screening, with detection in the community and planned treatment can reduce the mortality of the disease by 58%. Screening programmes for AAA have recently been approved for men aged 65 years, in both the UK and the USA. The proposed UK National Screening Programme is outlined briefly. Conclusion: If the aim of treatment is to reduce the mortality of the disease as a whole, resources would be better spent on screening programmes for AAA, rather than developing increasingly sophisticated operative techniques that could only reduce the overall death from AAA by a few percent.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Economics

Evaluating the Cost-Effectiveness of Changes to the Surveillance Intervals in the UK Abdominal Aortic Aneurysm Screening Programme

Michael J. Sweeting, John Marshall, Matthew Glover, Akhtar Nasim, Matthew J. Bown

Summary: The study found that lengthening the surveillance intervals in the UK Abdominal Aortic Aneurysm Screening Programme, especially for small AAAs, can marginally reduce the incremental cost per QALY of the program. However, it is unclear whether the cost savings from refining surveillance strategies justifies a change in clinical practice.

VALUE IN HEALTH (2021)

添加到收藏夹

Article Surgery

Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database

Kelli L. Summers, Edmund K. Kerut, Claudie M. Sheahan, Malachi G. Sheahan

Summary: This study analyzed data from a large-scale AAA screening program in the United States and found that male gender, smoking, cardiac disease, family history, and advancing age are high-risk factors for AAA. Current smoking status was the most significant risk factor.

JOURNAL OF VASCULAR SURGERY (2021)

添加到收藏夹

Article Surgery

Identification and characterization of new candidates for abdominal aortic aneurysm screening in patients outside of current accepted guidelines

Neil Patel, Varun K. Dalmia, Matthew Carnevale, Evan Lipsitz, Jeffrey Indes

Summary: This study aimed to determine the prevalence of abdominal aortic aneurysm (AAA) in patients outside of the current screening guidelines and analyze the outcomes. Results showed that male ever-smokers aged 45 to 65, male never-smokers aged 65 to 75, male never-smokers aged older than 75, and female ever-smokers aged 65 or older had a prevalence of AAA greater than 1%. In addition, the risk of rupture increased over time in these patients. Patients who underwent AAA repair had significantly lower rates of mortality, stroke, and myocardial infarction.

JOURNAL OF VASCULAR SURGERY (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Pathogenesis and management of abdominal aortic aneurysm

Jonathan Golledge, Shivshankar Thanigaimani, Janet T. Powell, Phil S. Tsao

Summary: Abdominal aortic aneurysm (AAA) causes a high number of deaths worldwide every year, but no drug therapy has been proven to effectively limit AAA growth in randomized controlled trials. Genome-wide association studies have identified potential drug targets, and treatments to reduce low-density lipoprotein cholesterol and smoking cessation are also being considered. However, previous placebo-controlled randomized trials have not shown convincing evidence of drug efficacy, mainly due to limitations such as small sample sizes and poor participant retention. Further large prospective studies on other targets are needed to address this issue.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Surgery

Association Between Serum MicroRNAs and Abdominal Aortic Aneurysm Diagnosis and Growth

Shivshankar Thanigaimani, Vikram Iyer, John Bingley, Daniel Browne, James Phie, Denise Doolan, Jonathan Golledge

Summary: This study examined the association between serum microRNAs (miRNAs) and diagnosis and growth of abdominal aortic aneurysm (AAA), and tested their diagnostic and prognostic value. The expression levels of 800 miRNA tags were assessed in AAA patients, healthy controls, and patients with peripheral artery disease (PAD). The miRNAs let-7b-5p and miR-548n improved the ability to diagnose AAA, but none of the miRNAs had independent prognostic value in predicting AAA growth.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Repair of Abdominal Aortic Aneurysms JACC Focus Seminar, Part 1

Sara E. Hensley, Gilbert R. Upchurch

Summary: Abdominal aortic aneurysms (AAAs) are defined as aortic dilation greater than 3 cm and affect over 1 million people in the United States. Risk factors for AAA include male sex, family history, smoking, Caucasian ethnicity, and age. Regular ultrasound surveillance is recommended for patients with known AAA. Medical management, including smoking cessation and blood pressure control, is recommended for asymptomatic patients who do not meet the intervention threshold. Repair options include endovascular and open surgical repair with good long-term outcomes. Elective repair is generally recommended for men with AAA greater than 5.5 cm and women with AAA greater than 5.0 cm.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Article Surgery

Epidemiology of endovascular and open repair for abdominal aortic aneurysms in the United States from 2004 to 2015 and implications for screening

Kirsten D. Dansey, Rens R. B. Varkevisser, Nicholas J. Swerdlow, Chun Li, Livia E. V. M. de Guerre, Patric Liang, Christina Marcaccio, Thomas F. X. O'Donnell, Brett J. Carroll, Marc L. Schermerhorn

Summary: This study found that the majority of patients who underwent repair for ruptured AAAs did not meet the screening criteria, especially those aged over 75, under 65, and women. Endovascular repair was the primary treatment for both ruptured and intact AAAs with relatively low in-hospital mortality rates.

JOURNAL OF VASCULAR SURGERY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Abdominal Aortic Aneurysm: Can the Anaconda (TM) Custom-Made Device Deliver? An International Perspective

Matti Jubouri, Abedalaziz O. Surkhi, Sven Z. C. P. Tan, Damian M. Bailey, Ian M. Williams, Mohamad Bashir

Summary: This study analyzed the international use of the Terumo Aortic Fenestrated Anaconda (TM) device over a 9-year period in 27 countries across 6 continents, with a total of 5,030 devices implanted. The Anaconda (TM) showed superiority in treating complex aortic anatomy and achieving excellent clinical results. The device was primarily used due to competitor rejection or surgeon preference, and most devices were implanted within 6-8 weeks of diagnosis.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Article Surgery

Outcomes in Men From the NHS Abdominal Aortic Aneurysm Screening Programme With a Large Aneurysm Referred for Intervention

Lewis Meecham, Jo Jacomelli, Meryl Davis, Arun Pherwani, Tim Lees, Jonothan J. Earnshaw

Summary: The study examined the referral and treatment outcomes of men in the NHS Abdominal Aortic Aneurysm Screening Programme, revealing a low rate of refusal for treatment and significant regional variation in the proportion undergoing endovascular repair. Surgical interventions were consistently carried out with low peri-operative mortality rates.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Contemporary Management of Abdominal Aortic Aneurysms

Kofi B. Quaye, Neena Pack, Timothy Wilson-Byrne, Chandler A. Long

Summary: Advancements in endovascular technologies have allowed us to treat more patients. Further research is warranted on non-operative medical therapies.

CURRENT CARDIOLOGY REPORTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Identification of PTPN22 as a potential genetic biomarker for abdominal aortic aneurysm

Peng Ruan, Lei Gao, Hui Jiang, Tianshu Chu, Jianjun Ge, Xiang Kong

Summary: This study found that the gene encoding protein tyrosine phosphatase non-receptor type 22 (PTPN22) may be a valuable diagnostic biomarker for abdominal aortic aneurysm (AAA). Integrative bioinformatics analysis and cellular validation demonstrated consistently upregulated expression of PTPN22 in aortic tissues and peripheral blood cells of AAA patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Article Surgery

Impact of interfacility transfer of ruptured abdominal aortic aneurysm patients

Sungho Lim, Stephen Kwan, Benjamin D. Colvard, Alexandre d'Audiffret, Vikram S. Kashyap, Jae S. Cho

Summary: This study evaluated the effects of interfacility transfer (IT) on mortality after repair of ruptured abdominal aortic aneurysm (rAAA), using a contemporary administrative database. The results showed that IT did not affect the mortality rates after endovascular repair, but it improved the mortality rates for open repair, particularly in high-volume hospitals.

JOURNAL OF VASCULAR SURGERY (2022)

添加到收藏夹

Article Surgery

Endurant stent graft demonstrates promising outcomes in challenging abdominal aortic aneurysm anatomy

Bibombe P. Mwipatayi, Joseph Faraj, Olufemi Oshin, Robert Fitridge, Jackie Wong, Marc L. Schermerhorn, Jean-Pierre Becquemin, Dittmar Boeckler, Vincente Riambau, Joep A. W. Teijink, Marc R. H. M. van Sambeek, Hence Verhagen

Summary: This study aimed to evaluate the 5-year safety and effectiveness outcomes of patients treated with Endurant stent graft within and outside the approved indications for use (IFU) in the ENGAGE registry. The analysis found no differences in all-cause mortality, aneurysm-related mortality, and secondary procedures between within and outside IFU patients during the 5-year follow-up.

JOURNAL OF VASCULAR SURGERY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

ADAR1 Non-Editing Function in Macrophage Activation and Abdominal Aortic Aneurysm

Dunpeng Cai, Chenming Sun, Takashi Murashita, Xingyi Que, Shi-You Chen

Summary: This study reveals the crucial role of macrophage activation in abdominal aortic aneurysm (AAA) development. It identifies adenosine deaminase acting on RNA (ADAR1) as a novel mechanism underlying macrophage activation and AAA formation.

CIRCULATION RESEARCH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Circulating Extracellular Vesicles: Their Role in Patients with Abdominal Aortic Aneurysm (AAA) Undergoing EndoVascular Aortic Repair (EVAR)

Francesco Lorenzo Serafini, Andrea Delli Pizzi, Pasquale Simeone, Alberto Giammarino, Cristian Mannetta, Michela Villani, Jacopo Izzi, Davide Buca, Giulia Catitti, Piero Chiacchiaretta, Stefano Trebeschi, Sebastiano Miscia, Massimo Caulo, Paola Lanuti

Summary: Abdominal aortic aneurysm (AAA) is a common aortic disease that can be treated with open surgical repair (OSR) or endovascular aortic repair (EVAR). Follow-up monitoring using computed tomography angiography (CTA) for 5 years is necessary to prevent complications. However, CTA involves high radiation exposure. This study explores the potential of peripheral-blood-circulating extracellular vesicles (pbcEVs) as biomarkers for EVAR complications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

暂无数据

暂无数据

© Peeref 2019-2024. All rights reserved.